Mark Currie

Director/Board Member at IRONWOOD PHARMACEUTICALS, INC.

Net worth: 3 M $ as of 30/08/2026

71 year

61 connections

Health Technology

Commercial Services

Consumer Services

Profile

Mark G.
Currie currently works at Science Exchange, Inc., as Director from 2020, Antag Therapeutics ApS, as Director, Sea Pharmaceuticals LLC, as Director from 2021, Ironwood Pharmaceuticals, Inc., as Independent Director from 2019, and Iaso Ventures LP, as Partner.
Dr. Currie also formerly worked at Monsanto Co., as Director-Arthritis & Inflammation, G.D.
Searle & Co., Inc., as Director-Arthritis & Inflammation, Sumitomo Pharma America, Inc., as Vice President-Discovery Research from 1999 to 2002, Ironwood Pharmaceuticals, Inc., as Chief Scientific Officer, President-R&D, Senior VP from 2002 to 2019, and Cyclerion Therapeutics, Inc., as President & Chief Scientific Officer from 2019 to 2020.
Dr. Currie received his doctorate degree from Wake Forest School of Medicine and undergraduate degree from the University of South Alabama.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
IRONWOOD PHARMACEUTICALS, INC. CLASS A 0.41%	15/06/2026	676,900 ( 0.41% )	3 M $	30/08/2026

Mark Currie active positions

Companies	Position	Start
IRONWOOD PHARMACEUTICALS, INC.	Director/Board Member	31/12/2018
Science Exchange, Inc. Science Exchange, Inc. Packaged SoftwareTechnology Services Provides life sciences procurement and supplier management SaaS solutions for biotech companies	Director/Board Member	11/02/2020
Sea Pharmaceuticals LLC Sea Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Operates as a neurotherapeutics research and development company	Director/Board Member	31/01/2021
Antag Therapeutics ApS Antag Therapeutics ApS Medical/Nursing ServicesHealth Services Provides obesity, diabetes and overweight therapy services	Director/Board Member	-
Iaso Ventures LP Iaso Ventures LP Investment ManagersFinance Functions as a venture capital fund	Corporate Officer/Principal	-

All active positions of Mark Currie

Former positions of Mark Currie

Companies	Position	End
CYCN THERNPV	President	30/11/2020
IRONWOOD PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	28/02/2019
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases	Corporate Officer/Principal	31/07/2002
G.D. Searle & Co., Inc. G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products	Corporate Officer/Principal	-
░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-

See the detail of Mark Currie's experience

Training of Mark Currie

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Currie's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases	Health Technology
Monsanto Co. Monsanto Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company controlling insects and weeds & manufactures seeds and genomics	Commercial Services
Wake Forest School of Medicine Wake Forest School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ironwood Pharmaceuticals, Inc. Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products	Health Technology
G.D. Searle & Co., Inc. G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products	Process Industries
University of South Alabama University of South Alabama Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Science Exchange, Inc. Science Exchange, Inc. Packaged SoftwareTechnology Services Provides life sciences procurement and supplier management SaaS solutions for biotech companies	Technology Services
Sea Pharmaceuticals LLC Sea Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Operates as a neurotherapeutics research and development company	Commercial Services
Antag Therapeutics ApS Antag Therapeutics ApS Medical/Nursing ServicesHealth Services Provides obesity, diabetes and overweight therapy services	Health Services
Cyclerion Therapeutics, Inc. Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases	Health Technology
Iaso Ventures LP Iaso Ventures LP Investment ManagersFinance Functions as a venture capital fund	Finance